{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:40:01Z","timestamp":1776922801538,"version":"3.51.2"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The F-18 fluorodeoxyglucose positron emission\/computed tomography (FDG PET\/CT) has become an established diagnostic imaging for malignancy. However, there are other diseases that can also be identified with FDG, some of them are infections such as tuberculosis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>In this case report, two patients showed multiple hypermetabolic tuberculosis lesions on FDG PET\/CT, with one of the patients having history of malignancy. The objective of the present case report is to emphasize the need to use other differential diagnosis techniques for tuberculosis especially in tuberculosis-endemic countries when interpreting FDG PET\/CT.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>By analyzing diagnostic imaging alone, there is a high chance of misinterpreting asymptomatic tuberculosis patient as having malignancy. Therefore, there is need for correlation with clinical data as well as other imaging modalities and PET\/CT with more specific tracer in order to differentiate malignancy from benign disease such as tuberculosis.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12880-020-00427-w","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T13:02:52Z","timestamp":1583413372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["False positive finding from malignancy-like lesions on FDG PET\/CT: case report of tuberculosis patients"],"prefix":"10.1186","volume":"20","author":[{"given":"Febby","family":"Hutomo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Yudistiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana Dewi","family":"Mulyanto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendra","family":"Budiawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"issue":"8","key":"427_CR1","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1007\/s00586-009-0966-0","volume":"18","author":"P Polley","year":"2009","unstructured":"Polley P, Dunn R. Noncontiguous spinal tuberculosis: incidence and management. Eur Spine J. 2009;18(8):1096\u2013101..","journal-title":"Eur Spine J"},{"issue":"5","key":"427_CR2","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1183\/09031936.00037207","volume":"30","author":"PM Khue","year":"2007","unstructured":"Khue PM, Truffot-Pernot C, Texier-Maugein J, Jarlier V, Robert J. A 10-year prospective surveillance of mycobacterium tuberculosis drug resistance in France 1995\u20132004. Eur Respir J. 2007;30(5):937\u201344.","journal-title":"Eur Respir J"},{"key":"427_CR3","volume-title":"Global Tuberculosis control: epidemiolog\u00eda, strategy, financing","author":"Who report 2009","year":"2009","unstructured":"Who report 2009. Global Tuberculosis control: epidemiolog\u00eda, strategy, financing. Geneva: World Health; 2009."},{"issue":"1","key":"427_CR4","first-page":"13","volume":"59","author":"I Kanga","year":"2015","unstructured":"Kanga I, Taylor JA, Jacobs C, Outerbridge G. Tuberculosis of the neuromusculoskeletal system: a review of two cases presenting as chiropractic patients. J Can Chiropr Assoc. 2015;59(1):13.","journal-title":"J Can Chiropr Assoc"},{"key":"427_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4046\/trd.2015.78.2.47","volume":"78","author":"JY Lee","year":"2015","unstructured":"Lee JY. Diagnosis and treatment of extra pulmonary tuberculosis. Tuberc Respir Dis. 2015;78:47\u201355.","journal-title":"Tuberc Respir Dis"},{"key":"427_CR6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2967\/jnumed.107.047787","volume":"49","author":"JW Fletcher","year":"2008","unstructured":"Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, Coleman RE, Wahl R, Paschold JC, Avril N, Einhorn LH, Suh WW, Samson D, Delbeke D, Gorman M, Shields AF. Recommendation on the use of 18F-FDG PET in oncology. J Nucl Med. 2008;49:480\u2013508.","journal-title":"J Nucl Med"},{"key":"427_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/00003072-200002000-00003","volume":"25","author":"SM Bakheet","year":"2000","unstructured":"Bakheet SM, Powe J, Kandil A, Ezzat A, Rostom A, Amartey J. F-18 FDG uptake in breast infection and inflammation. Clin Nucl Med. 2000;25:100\u20133.","journal-title":"Clin Nucl Med"},{"key":"427_CR8","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1182\/blood.V60.4.888.888","volume":"60","author":"DJ Weisdorf","year":"1982","unstructured":"Weisdorf DJ, Craddock PR, Jacob HS. Glycogenolysis versus glucose transport in human granulocytes: differential activation in phagocytosis and chemotaxis. Blood. 1982;60:888\u201393.","journal-title":"Blood"},{"key":"427_CR9","volume-title":"Canadian tuberculosis standards","author":"D Fisher","year":"2013","unstructured":"Fisher D, Elwood K. Nonrespiratory tuberculosis. In: Canadian thoracic society, Canadian Lung Association, and the Public Health Agency of Canada, editor. Canadian tuberculosis standards. 7th ed. Ottawa: Canadian Thoracic Society; 2013.","edition":"7"},{"key":"427_CR10","first-page":"1412","volume":"42","author":"H Zuang","year":"2001","unstructured":"Zuang H, Pourdehnad M, Lambright ES, Yamamoto AJ, Lanuti M, Li P, Mozley PD, Rossman MD, Albelda SM, Alavi A. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory process. J Nucl Med. 2001;42:1412\u20137.","journal-title":"J Nucl Med"},{"key":"427_CR11","first-page":"206","volume-title":"Seminars in nuclear medicine","author":"U Metser","year":"2007","unstructured":"Metser U, Even-Sapir E. Increased 18 F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography\/computed tomography (PET\/CT): accumulated data from four years of experience with PET\/CT. In: Seminars in nuclear medicine. Philadelphia: Elsevier; 2007. p. 206\u201322."},{"key":"427_CR12","first-page":"48","volume":"95","author":"ZG Wang","year":"2016","unstructured":"Wang ZG, Yu MM, Han Y, Wu FY, Yang GJ, Li DC, Liu SM. Correlation of Glut-2 and Glut-3 expression with F-18 FDG uptake in pulmonary inflammatory lesion. Medicine. 2016;95:48.","journal-title":"Medicine"},{"issue":"1","key":"427_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00296-003-0334-z","volume":"24","author":"M Hammoudeh","year":"2004","unstructured":"Hammoudeh M, Khanjar I. Skeletal tuberculosis mimicking seronegative spondyloarthropathy. Rheumatol Int. 2004;24(1):50\u20132.","journal-title":"Rheumatol Int"},{"key":"427_CR14","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s00259-007-0585-0","volume":"35","author":"IJ Kim","year":"2008","unstructured":"Kim IJ, Lee JS, Kim SJ, Kim YK, Jeong YJ, Jun S, Nam HY, Kim JS. Double-phase 18F-FDG PET-CT for determina- tion of pulmonary tuberculoma activity. Eur J Nucl Med Mol Imaging. 2008;35:808\u201314.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"427_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1378\/chest.108.2.415","volume":"108","author":"J Quist","year":"1995","unstructured":"Quist J, Hill AR. Serum lactate dehydrogenase (LDH) in Pneumocystis carinii pneumonia, tuberculosis and bacterial pneumonia. Chest. 1995;108(2):415\u20138.","journal-title":"Chest"},{"issue":"6","key":"427_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.4082\/kjfm.2013.34.6.413","volume":"34","author":"JI No","year":"2013","unstructured":"No JI, Yang JY, Hyun HJ, Yeon CS, Choi HJ. Factors associated with serum levels of carcinoembryonic antigen in healthy non-smokers. Korean J Fam Med. 2013;34(6):413\u20139. https:\/\/doi.org\/10.4082\/kjfm.2013.34.6.413.","journal-title":"Korean J Fam Med"},{"key":"427_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s40336-014-0075-x","volume":"2","author":"S Houshmand","year":"2014","unstructured":"Houshmand S, Salavati A, Basu S, et al. The role of dual and multiple time point imaging of FDG uptake in both normal and disease states. Clin Transl Imaging. 2014;2:281. https:\/\/doi.org\/10.1007\/s40336-014-0075-x.","journal-title":"Clin Transl Imaging"},{"issue":"1","key":"427_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12149-017-1220-1","volume":"32","author":"AHS Kartamihardja","year":"2018","unstructured":"Kartamihardja AHS, Kurniawati Y, Gunawan R. Diagnostic value of 99mTc-ethambutol scintigraphy in tuberculosis: compared to microbiological and histopathological tests. Ann Nucl Med. 2018;32(1):60\u20138.","journal-title":"Ann Nucl Med"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-020-00427-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12880-020-00427-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-020-00427-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:08:39Z","timestamp":1614902919000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-020-00427-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["427"],"URL":"https:\/\/doi.org\/10.1186\/s12880-020-00427-w","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]},"assertion":[{"value":"4 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Appl\u0131cable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}